Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.002 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.093 | 0.002 |
mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.086 | 0.003 |
mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.004 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.004 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |